Such data indicated that treatment with BAPTA-AM, like TRPM7 silencing, to reduce the levels of [Ca2+]i inhibited the migration, invasion and wound healing in ovarian cancer cells by attenuating the PI3K/AKT signaling. This evidence concerns the gene TRPM7 and ovarian cancer.